J King, M McCall, A Cannella… - JAIDS Journal of …, 2011 - journals.lww.com Atripla is the first fixed-dose combination (FDC) available in the United States to combine 2 different classes of antiretroviral drugs in a single pill, which can be taken once daily. This tablet combines the active ingredients of efavirenz, a nonnucleoside reverse transcriptase inhibitor, with ... Related articles
KS Amidon, P Langguth, H Lennernäs… - Clinical Pharmacology …, 2011 - nature.com The demonstration of bioequivalence (BE) is an essential requirement for ensuring that patients receive a product that performs as indicated by the label. The BE standard for a particular product is set by its innovator, and this standard must subsequently be matched by generic drug ...
S Patel, V Chauhan, J Mandal, S Shah… - Clinical …, 2011 - ncbi.nlm.nih.gov BACKGROUND: Mycophenolate mofetil (MMF) is an immunosuppressant indicated for prophylaxis of acute organ transplant rejection. Generic MMF is less costly than the branded product, but European regulatory authorities require bioequivalence studies for the marketing of ... All 2 versions
A Sputtek, M Lioznov, N Kröger… - Cytotherapy, 2011 - informahealthcare.com Background aims. We investigated two different plastic freezing bags, namely the most recently US Food and Drug Administration (FDA)-approved CryoMACS ® freezing bag (200-074-402) from Miltenyi Biotec and the familiar Cryocyte ® freezing bag (R4R9955) ... Related articles - All 3 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
